Showing results (1-10 of 394) with videos related to

Sort By:
Pageof 40
Molecular Diagnosis & Therapy|November 25, 2015
PI3K/AKT Pathway and Its Mediators in Thyroid CarcinomasZahra Nozhat, Mehdi Hedayati
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 15, 2016
Medullary thyroid carcinoma: a review on ethical considerations in treatment of childrenZahra Nozhat, Mehdi Hedayati
Asian Pacific Journal of Cancer Prevention : APJCP|May 12, 2016
Can the Serum Level of Myostatin be Considered as an Informative Factor for Cachexia Prevention in Patients with Medullary Thyroid Cancer?Mehdi Hedayati, Zahra Nozhat, Masoomeh Hannani
Anti-Cancer Agents in Medicinal Chemistry|January 4, 2021
Different Methods for Cell Viability and Proliferation Assay: Essential Tools in Pharmaceutical StudiesZahra Nozhat, Mina S Khalaji, Mehdi Hedayati, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|September 23, 2018
Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell linesZahra Nozhat, Samira Mohammadi-Yeganeh, Feridoun Azizi, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 19, 2021
Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell LineZahra Nozhat, Maryam Zarkesh, Enke Baldini, et al.
Pathology, Research and Practice|December 20, 2021
Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancerMaryam Zarkesh, Noman Arab, Seyed Mohmmad Tavangar, et al.
Life Sciences|March 21, 2019
BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology casesMaryam Zarkesh, Azita Zadeh-Vakili, Mahdi Akbarzadeh, et al.
Molecular Biology Reports|July 2, 2025
Epigenetic silencing of the tumor suppressor TIMP-3 gene in upstream CpG islands in thyroid neoplasms: a cross-sectional study with systematic reviewMaryam Zarkesh, Noman Arab, Raziyeh Abooshahab, et al.
Cancer Cell International|October 11, 2022
CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic reviewMaryam Zarkesh, Noman Arab, Raziyeh Abooshahab, et al.
Pageof 40